The DOI matches its Crossref record.
Accelerated Restitution of Endothelial Integrity and Endothelium-Dependent Function After phVEGF 165 Gene Transfer
Abstract
Background Delinquent reendothelialization (rET) has been shown to have a permissive, if not facilitatory, impact on smooth muscle cell proliferation. This inverse relation has been attributed to certain functions of the endothelium, including barrier regulation of permeability, thrombogenicity, and leukocyte adherence, as well as production of growth-inhibitory molecules. Accordingly, the present investigation was designed to test the hypothesis that an endothelial cell (EC) mitogen could serve as the basis for a novel gene therapy strategy designed to facilitate EC regeneration, reduce neointimal thickening, and promote recovery of EC dysfunction after balloon injury. Methods and Results New Zealand White rabbits underwent simultaneous balloon injury and gene transfer of one femoral artery with phVEGF 165 , encoding the 165–amino acid isoform of vascular endothelial growth factor (VEGF), or pGSVLacZ. In each animal transfected with phVEGF 165 or pGSVLacZ, the contralateral femoral artery was also subjected to balloon injury but not to gene transfer. For pGSVLacZ, rET remained incomplete at 4 weeks after transfection; in contrast, phVEGF 165 produced prompt rET, which was 95% complete by 1 week. Furthermore, rET in the contralateral, balloon-injured, nontransfected limb of the VEGF group was similarly accelerated. Consequently, intimal thickening was diminished, thrombotic occlusion was less frequent, and recovery of EC-dependent vasomotor reactivity was accelerated in VEGF transfectants compared with control animals. A similar benefit was observed for the contralateral, balloon-injured, nontransfected limb. Conclusions Catheter-mediated, site-specific arterial gene transfer of phVEGF 165 can accelerate rET at local and remote sites, leading to inhibition of neointimal thickening, reduction in thrombogenicity, and restoration of endothelium-dependent vasomotor reactivity. These findings support the notion that gene transfer encoding for an EC-specific mitogen may be useful for preventing the complications, including restenosis, of balloon angioplasty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1560 · Cited by 1,200
Self-citationInflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Self-citationWalter, D. H., Rittig, K., Bahlmann, F. H., Kirchmair, R., Silver, M., Murayama, T., Nishimura, H., Losordo, D. W., Asahara, T., & Isner, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000018166.84319.55 · Cited by 918
Self-citationGriffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Zachary, I. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00268-6 · Cited by 662
Stromal Cells Protect against Acute Tubular Injury via an Endocrine Effect
Bi, B., Schmitt, R., Israilova, M., Nishio, H., & Cantley, L. G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020140 · Cited by 515
Molecular Basis of Restenosis and Drug-Eluting Stents
Costa, M. A., & Simon, D. I. (2005) · Circulation · doi:10.1161/01.cir.0000163587.36485.a7 · Cited by 510
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Principals of neovascularization for tissue engineering
Nomi, M., Atala, A., Coppi, P. D., & Soker, S. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00008-0 · Cited by 392
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
Tsurumi, Y., Murohara, T., Krasinski, K., Chen, D., Witzenbichler, B., Kearney, M., Couffinhal, T., & Isner, J. M. (1997) · Nature Medicine · doi:10.1038/nm0897-879 · Cited by 358
Self-citationAutiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Covalently conjugated VEGF–fibrin matrices for endothelialization
Zisch, A. H., Schenk, U., Schense, J. C., Sakiyama-Elbert, S. E., & Hubbell, J. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00266-8 · Cited by 350
KIPSHIDZE, N., DANGAS, G., TSAPENKO, M., MOSES, J., LEON, M., KUTRYK, M., & SERRUYS, P. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01083-6 · Cited by 201
Dulak, J., Józkowicz, A., Dembinska-Kiec, A., Guevara, I., Zdzienicka, A., Zmudzinska-Grochot, D., Florek, I., Wójtowicz, A., Szuba, A., & Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.659 · Cited by 329
Vascularization—The Conduit to Viable Engineered Tissues
Kaully, T., Kaufman-Francis, K., Lesman, A., & Levenberg, S. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0193 · Cited by 317
Bouloumié, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00228-4 · Cited by 281
Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R. A., Martin, J., & Zachary, I. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01481-6 · Cited by 255
Supp, D. M., Supp, A. P., Boyce, S. T., & Bell, S. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00824.x · Cited by 120
Metadata
- Authors
- Asahara, T., Chen, D., Tsurumi, Y., Kearney, M., Rossow, S., Passeri, J., Symes, J. F., & Isner, J. M.
- Venue
- Circulation
- Published
- 1996-12-15
- Volume
- 94
- Issue
- 12
- Pages
- 3291-3302
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2013641657
- Cited by
- 249
- References
- 0
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.